Zobrazeno 1 - 9
of 9
pro vyhledávání: '"MESH: Idiopathic Pulmonary Fibrosis"'
Autor:
Marchal-Duval, Emmeline, Homps-Legrand, Méline, Froidure, Antoine, Jaillet, Madeleine, Ghanem, Mada, Lou, Deneuville, Justet, Aurélien, Maurac, Arnaud, Vadel, Aurelie, Fortas, Emilie, Cazes, Aurelie, Joannes, Audrey, Giersh, Laura, Mal, Herve, Mordant, Pierre, Piolot, Tristan, Truchin, Marin, Mounier, Carine, Schirduan, Ksenija, Korfei, Martina, Gunther, Andreas, Mari, Bernard, Jaschinski, Frank, Crestani, Bruno, Mailleux, Arnaud
Publikováno v:
eLife, Vol. 12, no.1, p. 1-32 (2023)
eLife
eLife, 2023, 12, pp.e79840. ⟨10.7554/eLife.79840⟩
eLife
eLife, 2023, 12, pp.e79840. ⟨10.7554/eLife.79840⟩
Matrix remodeling is a salient feature of idiopathic pulmonary fibrosis (IPF). Targeting cells driving matrix remodeling could be a promising avenue for IPF treatment. Analysis of transcriptomic database identified the mesenchymal transcription facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1996ed1dcf65d6fdb8ee48a755b89e39
https://hdl.handle.net/2078.1/276007
https://hdl.handle.net/2078.1/276007
Autor:
Dorine Fournier, Stéphane Jouneau, Guillaume Bouzillé, Elisabeth Polard, Marie-Noëlle Osmont, Lucie-Marie Scailteux
Publikováno v:
Pulmonary Pharmacology and Therapeutics
Pulmonary Pharmacology and Therapeutics, 2022, 76, pp.102149. ⟨10.1016/j.pupt.2022.102149⟩
Annual Meeting of French Society of Pharmacology and Therapeutics
Annual Meeting of French Society of Pharmacology and Therapeutics, Jun 2022, Lille, France. 36, pp.77-78, 2022
Pulmonary Pharmacology and Therapeutics, 2022, 76, pp.102149. ⟨10.1016/j.pupt.2022.102149⟩
Annual Meeting of French Society of Pharmacology and Therapeutics
Annual Meeting of French Society of Pharmacology and Therapeutics, Jun 2022, Lille, France. 36, pp.77-78, 2022
Introduction: While pirfenidone and nintedanib have greatly influenced the treatment of idiopathic pulmonary fibrosis (IPF), both drugs have significant early adverse drug reactions (ADRs) and almost nothing is known of their rare and delayed ADRs. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f463e5ba0ebf3d17710bd8bdd4015b
https://univ-rennes.hal.science/hal-03954444/document
https://univ-rennes.hal.science/hal-03954444/document
Publikováno v:
European Journal of Physical and Rehabilitation Medicine
European Journal of Physical and Rehabilitation Medicine, Edizioni Minerva Medica, 2019, 55 (1), pp.103-112. ⟨10.23736/S1973-9087.18.05093-1⟩
European Journal of Physical and Rehabilitation Medicine, Edizioni Minerva Medica, 2019, 55 (1), pp.103-112. ⟨10.23736/S1973-9087.18.05093-1⟩
International audience; Background: Pulmonary rehabilitation (PR) improves performance in the 6-min walk test (6MWT) in a subset of patients with fibrotic idiopathic interstitial pneumonia (f-IIP); however, a large proportion of patients does not res
Autor:
Bruno Crestani, Valérie Siroux
Publikováno v:
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2018, 51 (1), pp.1702663. ⟨10.1183/13993003.02663-2017⟩
European Respiratory Journal, 2018, 51 (1), pp.1702663. ⟨10.1183/13993003.02663-2017⟩
European Respiratory Journal, European Respiratory Society, 2018, 51 (1), pp.1702663. ⟨10.1183/13993003.02663-2017⟩
European Respiratory Journal, 2018, 51 (1), pp.1702663. ⟨10.1183/13993003.02663-2017⟩
For the first time, a role of air pollution in the development of idiopathic pulmonary fibrosis is suggested http://ow.ly/EH2V30hBapf
Autor:
Marie-Pierre Debray, Isabelle Monnet, Xavier Duval, Bruno Crestani, Benoit Wallaert, Emmanuel Bergot, Monique Dehoux, Abdellatif Tazi, J. Chapron, Dominique Israel-Biet, F. Mentré, Michel Brauner, Jacques Lacronique, Q. Dornic, Martine Reynaud-Gaubert, Philippe Delaval, Rachida Lebtahi, Michel Aubier
Publikováno v:
European Respiratory Journal
European Respiratory Journal, 2012, 39 (3), pp.772-5. ⟨10.1183/09031936.00113011⟩
European Respiratory Journal, European Respiratory Society, 2012, 39 (3), pp.772-5. 〈10.1183/09031936.00113011〉
European Respiratory Journal, European Respiratory Society, 2012, 39 (3), pp.772-5. ⟨10.1183/09031936.00113011⟩
European Respiratory Journal, 2012, 39 (3), pp.772-5. ⟨10.1183/09031936.00113011⟩
European Respiratory Journal, European Respiratory Society, 2012, 39 (3), pp.772-5. 〈10.1183/09031936.00113011〉
European Respiratory Journal, European Respiratory Society, 2012, 39 (3), pp.772-5. ⟨10.1183/09031936.00113011⟩
To the Editors: Idiopathic pulmonary fibrosis (IPF) is the most frequent form of idiopathic interstitial pneumonia. It is a chronic, progressive and fatal disease of unknown aetiology, characterised by histological features of usual interstitial pneu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd2ceb0bc94c989e4cf41a422f7151e
https://hal.archives-ouvertes.fr/hal-00873601
https://hal.archives-ouvertes.fr/hal-00873601
Autor:
Dominique, Valeyre, Olivia, Freynet, Geneviève, Dion, Diane, Bouvry, Isabella, Annesi-Maesano, Hilario, Nunes
Publikováno v:
La Presse Médicale
La Presse Médicale, Elsevier Masson, 2010, 39 (1), pp.53-9. 〈10.1016/j.lpm.2009.09.015〉
La Presse Médicale, 2010, 39 (1), pp.53-9. ⟨10.1016/j.lpm.2009.09.015⟩
La Presse Médicale, Elsevier Masson, 2010, 39 (1), pp.53-9. 〈10.1016/j.lpm.2009.09.015〉
La Presse Médicale, 2010, 39 (1), pp.53-9. ⟨10.1016/j.lpm.2009.09.015⟩
International audience; Diffuse interstitial lung diseases (DILD) cover more than 200 conditions classified in 4 groups: secondary DILD; sarcoidosis; particular DILDs and idiopathic interstitial pneumonias. Overall, these diseases have a prevalence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c2bc45ecf7f1fabfb02b3b1783a0ffd8
https://hal.sorbonne-universite.fr/hal-00595787
https://hal.sorbonne-universite.fr/hal-00595787
Autor:
Amara, Nadia, Goven, Delphine, Prost, Fabienne, Muloway, Rachel, Crestani, Bruno, Boczkowski, Jorge
Publikováno v:
Thorax
Thorax, BMJ Publishing Group, 2010, 65 (8), pp.733-8. ⟨10.1136/thx.2009.113456⟩
Thorax, BMJ Publishing Group, 2010, 65 (8), pp.733-8. ⟨10.1136/thx.2009.113456⟩
International audience; BACKGROUND: Persistence of myofibroblasts is believed to contribute to the development of fibrosis in idiopathic pulmonary fibrosis (IPF). Transforming growth factor beta1 (TGFbeta1) irreversibly converts fibroblasts into path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::305a40964b64aca53decb6ac483387ce
https://www.hal.inserm.fr/inserm-00515220
https://www.hal.inserm.fr/inserm-00515220
Autor:
Amara, Nadia, Goven, Delphine, Prost, Fabienne, Muloway, Rachel, Crestani, Bruno, Boczkowski, Jorge
Publikováno v:
Thorax
Thorax, BMJ Publishing Group, 2010, 65 (8), pp.733-8. ⟨10.1136/thx.2009.113456⟩
Thorax, BMJ Publishing Group, 2010, 65 (8), pp.733-8. ⟨10.1136/thx.2009.113456⟩
International audience; BACKGROUND: Persistence of myofibroblasts is believed to contribute to the development of fibrosis in idiopathic pulmonary fibrosis (IPF). Transforming growth factor beta1 (TGFbeta1) irreversibly converts fibroblasts into path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1398::305a40964b64aca53decb6ac483387ce
https://www.hal.inserm.fr/inserm-00515220
https://www.hal.inserm.fr/inserm-00515220
Autor:
Nicolas Girerd, Ichraq Latar
Publikováno v:
Chest
Chest, American College of Chest Physicians, 2015, 147 (5), pp.e189. ⟨10.1378/chest.14-3246⟩
Chest, American College of Chest Physicians, 2015, 147 (5), pp.e189. ⟨10.1378/chest.14-3246⟩
International audience